TrialBlood advances2025
Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas.
Dai Chihara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
TrialBlood advances2025
Dai Chihara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.